Phase II Study of GTx024 in Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: GTx-024 9mg
Sponsor: GTx